GLP-1 Providers in Virginia (2026)

365 of the 444 sellers that publish a state list include Virginia, the 7th-most of the 50 states and DC. 226 of them ship to all 50 states, and 12 serve 15 states or fewer. Across the 253 with a regular monthly price, the middle figure is $175/mo.

Virginia Medicaid covers GLP-1 drugs prescribed for weight loss, once a prior authorization is approved. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

Sellers and prices are broken out by drug on the semaglutide in Virginia and tirzepatide in Virginia pages.

Who Ships GLP-1s to Virginia

1. WellMedRx $49/mo
2. Collective $59/mo
3. CoreAge Rx $79/mo

Lowest regular prices for Virginia: WellMedRx at $49/mo, Collective at $59/mo and CoreAge Rx at $79/mo.

Smaller-footprint sellers that include Virginia: TD Tele-Doc Weight Loss (2 states), Rivas Medical Weight Loss (3 states), Clover Meds (4 states), Gaya Wellness (5 states) and The Sanctuary Wellness Institute (5 states), plus 7 more.

9 sellers that list 30 or more states leave Virginia off, among them New Tides, MadeMed, Gentle Health, Mixx Health & Wellness and Bloom MD.

Seller counts next door: District of Columbia 118, Kentucky 350, Maryland 362, North Carolina 358, Tennessee 353 and West Virginia 333.

Browse by medication

Virginia Medicaid and GLP-1 Coverage

Virginia Medicaid covers GLP-1 drugs prescribed for weight loss, once a prior authorization is approved. GLP-1s prescribed for type 2 diabetes are covered, with prior authorization.

• Wegovy to cut heart attack and stroke risk: covered with prior authorization (age 45 or older; prescribed by a cardiologist or vascular specialist; prior heart attack, stroke, or peripheral artery disease (ABI under 0.85 at rest); BMI of at least 27; no previous diagnosis of diabetes).
• Wegovy for the liver disease MASH: covered with prior authorization (fibrosis stage F2, F3).
• Zepbound for obstructive sleep apnea: covered with prior authorization (an AHI of at least 15; a BMI of at least 30; a CPAP trial first).
• Weight-loss GLP-1s for adolescents from age 12: covered with prior authorization.

In 2025, Virginia Medicaid paid for at least 227,419 GLP-1 prescriptions, including at least 28,955 for Ozempic, at least 24,209 for Wegovy, at least 27,595 for Mounjaro and at least 11,795 for Zepbound, about $230.0 million before manufacturer rebates. Drugs labeled for weight loss made up 23% of that spending.

Medicaid rules checked November 2026. Prescription counts: CMS State Drug Utilization Data. Check your eligibility

Specialist Clinics and Obesity in Virginia

Virginia has 794 practices in the federal provider registry that list obesity medicine, endocrinology or bariatric care, 9.01 per 100,000 residents (21st of 51). By specialty: 423 bariatric, 368 endocrinology and 15 obesity medicine. About 32.3% of adults here had obesity in 2024 (CDC), the 34th-highest rate of the 50 states and DC. Measured against the median state, Virginia has 0.89 times as much adult obesity per specialist practice.

Largest Cities in Virginia

Frequently Asked Questions